Xhemo Edlira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xhemo Edlira has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Anne Fajac
Service d’Oncogénétique, Hôpital Tenon, 75020 Paris, France
1 shared publication - Jean-Yves Boire
Member IEEE, EMBS, ERIM, Faculty of Medicine, BP38, 63001 Clermont-ferrand Cedex 1, France
1 shared publication - Pierre Levy
University of Paris Cité, HPB and Liver Transplantation, Clichy, France
1 shared publication
Latest Publications
- 1 August 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- Vol. 2007 (1094687X) , 4592-4594
MDRView: a visualization of the polymorphisms of MDR1(ABCB1) GENE in breast cancer
This paper presents the Generalized CaseView method applied to the study of polymorphisms of MDR1 (Multi Drug Resistant), a gene coding for a trans-membrane transporting protein. The data base contains Single nucleotide polymorphisms, their positions in cDNA, and the Area Under the Curve of drugs concentrations. The generalized CaseView method permits a compact visualization of these data. The main result is that pharmacokinetics of some anticancer drugs depends on the genotype.
- 1 August 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- Vol. 2007 (1094687X) , 4592-4594
MDRView: a visualization of the polymorphisms of MDR1(ABCB1) GENE in breast cancer
This paper presents the Generalized CaseView method applied to the study of polymorphisms of MDR1 (Multi Drug Resistant), a gene coding for a trans-membrane transporting protein. The data base contains Single nucleotide polymorphisms, their positions in cDNA, and the Area Under the Curve of drugs concentrations. The generalized CaseView method permits a compact visualization of these data. The main result is that pharmacokinetics of some anticancer drugs depends on the genotype.